Sunteți pe pagina 1din 6


Nam, J., et al. (2013). "Surface engineering of inorganic nanoparticles for imaging
and therapy." Advanced drug delivery reviews 65(5): 622-648.
Larson, S. M., et al. (2015). "Radioimmunotherapy of human tumours." Nature
Reviews Cancer 15(6): 347-360.
Ningthoujam, R., et al. (2012). "Functionalized magnetic nanoparticles: concepts,
synthesis and application in cancer hyperthermia." Functionalized Materials: 229260.
Gallo, J. and N. J. Long (2015). "Nanoparticulate MRI Contrast Agents." The
Chemistry of Molecular Imaging: 199-224.
Jokerst, J. V., et al. (2011). "Nanoparticle PEGylation for imaging and therapy."
Nanomedicine 6(4): 715-728.
Na, H. B., et al. (2009). "Inorganic nanoparticles for MRI contrast agents."
Advanced Materials 21(21): 2133-2148.
ElDakdouki, M. H., et al. (2013). "Methods for Magnetic Nanoparticle Synthesis
and Functionalization." Chemistry of Bioconjugates: Synthesis, Characterization,
and Biomedical Applications: 281-314.
Wust, P., et al. (2002). "Hyperthermia in combined treatment of cancer." The
lancet oncology 3(8): 487-497.
Hurwitz, M. and P. Stauffer (2014). Hyperthermia, radiation and chemotherapy:
the role of heat in multidisciplinary cancer care. Seminars in oncology, Elsevier.
Shubayev, V. I., et al. (2009). "Magnetic nanoparticles for theragnostics."
Advanced drug delivery reviews 61(6): 467-477.
Maldonado, C. R., et al. (2013). "Nano-functionalization of metal complexes for
molecular imaging and anticancer therapy." Coordination Chemistry Reviews
257(19): 2668-2688.

Lin, W., et al. (2009). "Magnetic nanoparticles for early detection of cancer by
magnetic resonance imaging." MRS bulletin 34(06): 441-448.
Chiche, A., et al. (2007). "Hyperthermiadescription of a method and a review of
clinical applications." Reports of Practical Oncology & Radiotherapy 12(5): 267275.
Emami, B. and C. W. Song (1984). "Physiological mechanisms in hyperthermia: a
review." International Journal of Radiation Oncology* Biology* Physics 10(2):
Vaupel, P. and F. Kallinowski (1987). Physiological effects of hyperthermia.
Hyperthermia and the therapy of malignant tumors, Springer: 71-109.
Fleming, S. (2003). "The molecular biology of cancer: the basics." Surgery
(Oxford) 21(11): iii-vi.
Siegel, R. L., et al. (2015). "Cancer statistics, 2015." CA: a cancer journal for
clinicians 65(1): 5-29.
Nair, M. K., et al. (2005). "Cancer: Current scenario, intervention strategies and
projections for 2015." Burden of Disease in India: 219.
Yousaf, M. Z., et al. (2013). "Magnetic nanoparticle-based
nanodiagnostics." Chinese Physics B 22(5): 058702.


Selvan, S. T., et al. (2009). "Functional and multifunctional nanoparticles for

bioimaging and biosensing." Langmuir 26(14): 11631-11641.
Sharma, P. K., et al. (2011). "Advances
nanoparticles." Adv. Mater. Lett 2: 246-263.




Leamon, C. P. and J. A. Reddy (2004). "Folate-targeted chemotherapy."

Advanced drug delivery reviews 56(8): 1127-1141.
Leamon, C. P. (2008). "Folate-targeted drug strategies for the treatment of
cancer." Current opinion in investigational drugs (London, England: 2000) 9(12):
Shih, J. L. A. and R. M. Brugger (1992). "Gadolinium as a neutron capture
therapy agent." Medical physics 19(3): 733-744.
Rosen, B. R. and T. J. Brady (1993). "Future uses of MR imaging agents."
Journal of computer assisted tomography 17: S36-S42.

Alkilany, A. M., et al. (2012). "Gold nanorods: their potential for photothermal
therapeutics and drug delivery, tempered by the complexity of their biological
interactions." Advanced drug delivery reviews 64(2): 190-199.
Chen, H., et al. (2013). "Gold nanorods and their plasmonic properties." Chemical
Society Reviews 42(7): 2679-2724.